CureOne News

Press Release

ASCO’s TAPUR Study Continues its Expansion of Sites, Participants, and Collaborators

Chicago June 3, 2017 – The American Society of Clinical Oncology’s (ASCO®) Targeted Agent and Profiling Utilization Registry (TAPUR) Study continues to expand and now has more than 300 participants enrolled on study drug, more than 100 sites, new partnerships, and a revised protocol to lower the age of eligibility.

CONTINUE READING…

Press Release

CureOne™ Announces Foundation Medicine Participation in its N1 Registry

Washington D.C. June 3, 2017 – CureOne (formerly known as MED-C), a non-profit organization dedicated to advancing precision medicine, is proud to announce the participation of Foundation Medicine as a cornerstone laboratory in CureOne’s N1 Registry™

CONTINUE READING…

Press Release

CureOne™ Announces Partnership with Guardant Health

Washington D.C. June 3, 2017 – CureOne (formerly known as MED-C), a non-profit organization dedicated to advancing precision medicine, is proud to announce the participation of Guardant Health, the leader in comprehensive liquid biopsy testing, as a cornerstone laboratory in CureOne’s N1 Registry™.

CONTINUE READING…

Press Release

Molecular Evidence Development Consortium (MED-C) Announces Name Change To CureOne

Washington D.C. June 1, 2017 – The Molecular Evidence Development Consortium (MED-C), a non-profit organization seeking to advance precision medicine, announced today it is changing its corporate name to CureOne™. The name change reflects the company’s unwavering commitment to patients.

CONTINUE READING…